—

Bain Capital Life Sciences Investors, LLC

Q4 2025 13F Holdings

  • Location
    boston, MA
  • Num holdings

    19

  • Value ($000)

    $1,305,661

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001703031
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

HEARTFLOW INC

COM
42238D107
$362.86M
28 %

12,448,158

---

NEWAMSTERDAM PHARMA COMPANY

ORDINARY SHARES
N62509109
$256.31M
20 %

7,306,566

O
OLMA

OLEMA PHARMACEUTICALS INC

COM
68062P106
$212.72M
16 %

8,508,641

Y
YB4P

SAVARA INC

COM
805111101
$106.13M
8 %

17,600,621

---

PHARVARIS N V

COM
N69605108
$77.76M
6 %

2,802,081

---

SOLID BIOSCIENCES INC

COM NEW
83422E204
$44.62M
3 %

7,911,669

---

UPSTREAM BIO INC

COM
91678A107
$36.1M
3 %

1,329,544

---

X4 PHARMACEUTICALS INC

COM NEW
98420X202
$31.87M
2 %

7,967,454

D
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$30.64M
2 %

743,592

K
KYTX

KYVERNA THERAPEUTICS INC

COM
501976104
$29.23M
2 %

3,110,000

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 19